Zarina Bilgrami

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

Cassandra Wannan, Barnaby Nelson, Jean Addington et al. · Schizophrenia Bulletin · 2024 · 63 citations · Full text

Psychopathology, Psychiatric Evaluation, Psychotropic Medication +19

Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings

Zarina Bilgrami, Cansu Sarac, Agrima Srivastava et al. · Schizophrenia Research · 2022 · 46 citations · Full text

Psychopathology, Psychiatric Evaluation, Psychiatry +13

Negative symptoms and speech pauses in youths at clinical high risk for psychosis

Emma Stanislawski, Zarina Bilgrami, Cansu Sarac et al. · Schizophrenia · 2021 · 31 citations · Full text

Linking language features to clinical symptoms and multimodal imaging in individuals at clinical high risk for psychosis

Shalaila S. Haas, Gaëlle E. Doucet, Sahil Garg et al. · European Psychiatry · 2020 · 25 citations · Full text

Differential Expression of Anomalous Self-Experiences in Spontaneous Speech in Clinical High-Risk and Early-Course Psychosis Quantified by Natural Language Processing

Agrima Srivastava, Alexandria Selloni, Zarina Bilgrami et al. · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · 2023 · 13 citations · Full text

Natural Language Processing, Anomalous Self-experiences, Psychiatry +12